Free Trial

CASI Pharmaceuticals (CASI) Institutional Ownership

CASI Pharmaceuticals logo
$2.28 -0.05 (-2.15%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$2.28 0.00 (0.00%)
As of 09/12/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for CASI Pharmaceuticals (NASDAQ:CASI)

Current
Institutional Ownership
Percentage
22.23%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$4.10M
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$729.06K
Get CASI Insider Trade Alerts

Want to know when executives and insiders are buying or selling CASI Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CASI Institutional Buying and Selling by Quarter

CASI Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/12/2025 Foresite Capital Management VI LLC787,121$929K0.5%-40.8%6.399%
5/16/2025Woodline Partners LP164,365$355K0.0%+64.9%1.336%
2/17/2025Woodline Partners LP99,690$282K0.0%+226.5%0.644%
2/14/2025Foresite Capital Management VI LLC1,329,383$3.76M1.7%N/A8.582%
2/13/2025ADAR1 Capital Management LLC46,320$131K0.0%-28.6%0.299%
2/10/2025Wellington Shields & Co. LLC30,091$85K0.0%-30.2%0.194%
8/9/2024Renaissance Technologies LLC40,800$224K0.0%+10.9%0.304%
8/5/2024Wellington Shields Capital Management LLC89,217$491K0.1%-3.3%0.666%
5/4/2024Howland Capital Management LLC40,429$146K0.0%N/A0.302%
5/3/2024Wellington Shields Capital Management LLC92,217$333K0.1%-30.7%0.688%
5/11/2023Wellington Shields Capital Management LLC180,143$418K0.1%N/A1.352%
5/11/2023Wellington Shields & Co. LLC139,315$323K0.1%N/A1.046%
11/4/2022Prudential Financial Inc.11,000$29K0.0%N/A0.081%
9/16/2022Federated Hermes Inc.1,015,000$2.90M0.0%-90.0%7.460%
8/15/2022Wellington Shields Capital Management LLC213,250$610K0.1%-90.0%1.567%
8/12/2022Ikarian Capital LLC132,014$378K0.1%-90.0%0.970%
8/12/2022Wellington Shields & Co. LLC145,317$416K0.1%-90.0%1.068%
7/27/2022Bailard Inc.31,530$90K0.0%+25.6%0.232%
5/12/2022Wellington Shields Capital Management LLC2,132,547$1.73M0.2%-2.6%1.561%
5/9/2022Wellington Shields & Co. LLC1,453,190$1.18M0.4%+27.3%1.064%
2/16/2022Wellington Shields & Co. LLC1,141,190$913K0.2%-37.7%0.816%
2/15/2022Wellington Shields Capital Management LLC2,188,547$1.75M0.2%-3.1%1.566%
11/15/2021Marshall Wace LLP952,037$1.13M0.0%+325.6%0.681%
11/12/2021Renaissance Technologies LLC1,618,155$1.93M0.0%+4.6%1.158%
11/12/2021Geode Capital Management LLC944,729$1.12M0.0%+34.2%0.676%
11/12/2021Connor Clark & Lunn Investment Management Ltd.60,904$72K0.0%N/A0.044%
11/10/2021Goldman Sachs Group Inc.199,986$238K0.0%+32.3%0.143%
11/9/2021BlackRock Inc.1,165,942$1.39M0.0%-1.3%0.834%
8/26/2021Y Intercept Hong Kong Ltd16,246$25K0.0%N/A0.012%
8/25/2021Marshall Wace LLP223,709$347K0.0%N/A0.160%
8/17/2021Millennium Management LLC1,112,208$1.72M0.0%+1,211.7%0.796%
8/17/2021Price T Rowe Associates Inc. MD105,200$163K0.0%-32.3%0.075%
8/17/2021Prudential Financial Inc.16,600$26K0.0%N/A0.012%
8/17/2021Boothbay Fund Management LLC185,988$288K0.0%+14.8%0.133%
8/16/2021Squarepoint Ops LLC22,698$35K0.0%+107.4%0.016%
8/16/2021LMR Partners LLP30,360$47K0.0%N/A0.022%
8/16/2021Schonfeld Strategic Advisors LLC20,600$32K0.0%N/A0.015%
8/16/2021Charles Schwab Investment Management Inc.405,290$629K0.0%-20.0%0.290%
8/16/2021State Street Corp194,842$302K0.0%-81.3%0.139%
8/16/2021Tibra Equities Europe Ltd216,300$335K0.1%N/A0.155%
8/16/2021Goldman Sachs Group Inc.151,183$234K0.0%+143.6%0.108%
8/16/2021Marshall Wace LLP223,709$347K0.0%N/A0.160%
8/16/2021Wellington Shields Capital Management LLC2,258,264$3.50M0.4%+1.2%1.615%
8/13/2021Renaissance Technologies LLC1,546,306$2.40M0.0%+504.7%1.106%
8/13/2021Northern Trust Corp243,200$377K0.0%-70.4%0.174%
8/13/2021Geode Capital Management LLC703,888$1.09M0.0%-35.6%0.504%
8/13/2021Vanguard Group Inc.3,904,627$6.05M0.0%-7.6%2.793%
8/13/2021Bailard Inc.40,400$63K0.0%N/A0.029%
8/12/2021Dimensional Fund Advisors LP274,344$425K0.0%+4.6%0.196%
8/12/2021JPMorgan Chase & Co.191,523$296K0.0%+8.7%0.137%
8/12/2021Ergoteles LLC300,400$466K0.0%N/A0.215%
8/11/2021Bank of New York Mellon Corp36,436$56K0.0%-80.6%0.026%
8/11/2021BlackRock Inc.1,181,599$1.83M0.0%-70.5%0.845%
(Data available from 1/1/2016 forward)

CASI Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CASI shares?

During the previous two years, the following institutional investors and hedge funds held shares of CASI Pharmaceuticals shares: Foresite Capital Management VI LLC ($929K), Wellington Shields Capital Management LLC ($491K), Woodline Partners LP ($355K), Renaissance Technologies LLC ($224K), Howland Capital Management LLC ($146K), and ADAR1 Capital Management LLC ($131K), and Wellington Shields & Co. LLC ($85K).Learn more on CASI Pharmaceuticals' institutional investors.

What percentage of CASI Pharmaceuticals' stock is owned by institutional investors?

22.23% of CASI Pharmaceuticals' stock is owned by institutional investors. Learn more on CASI's institutional investor holdings.

Which institutional investors have been buying CASI Pharmaceuticals' stock?

The following institutional investors have purchased CASI Pharmaceuticals' stock in the last 24 months: Foresite Capital Management VI LLC ($1.33M), Woodline Partners LP ($133.83K), Howland Capital Management LLC ($40.43K), and Renaissance Technologies LLC ($4K).

How much institutional buying is happening at CASI Pharmaceuticals?

Institutional investors have bought a total of 1,463,216 shares in the last 24 months. This purchase volume represents approximately $4.10M in transactions.

Which of CASI Pharmaceuticals' major shareholders have been selling company stock?

The following institutional investors have sold CASI Pharmaceuticals stock in the last 24 months: Foresite Capital Management VI LLC ($542.26K), ADAR1 Capital Management LLC ($18.52K), and Wellington Shields & Co. LLC ($13K).

How much institutional selling is happening at CASI Pharmaceuticals?

Institutional investors have sold a total of 573,777 shares in the last 24 months. This volume of shares sold represents approximately $729.06K in transactions.



This page (NASDAQ:CASI) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners